China Resources Pharmaceutical Group Limited (HKG: 3320)
Hong Kong
· Delayed Price · Currency is HKD 5.43
-0.03 (-0.55%)
Dec 20, 2024, 4:08 PM HKT
China Resources Pharmaceutical Group Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 250,483 | 244,704 | 218,183 | 236,806 | 200,423 | 204,454 | Upgrade
|
| Revenue Growth (YoY) | 11.50% | 12.16% | -7.86% | 18.15% | -1.97% | 7.78% | Upgrade
|
| Cost of Revenue | 210,973 | 206,366 | 184,564 | 201,426 | 168,129 | 170,436 | Upgrade
|
| Gross Profit | 39,510 | 38,337 | 33,619 | 35,380 | 32,294 | 34,018 | Upgrade
|
| Selling, General & Admin | 25,588 | 25,252 | 21,999 | 23,792 | 21,611 | 24,411 | Upgrade
|
| Other Operating Expenses | 2,365 | 2,044 | 1,878 | 1,745 | 1,347 | 1,257 | Upgrade
|
| Operating Expenses | 27,953 | 27,296 | 23,878 | 25,537 | 22,958 | 25,668 | Upgrade
|
| Operating Income | 11,558 | 11,041 | 9,741 | 9,843 | 9,335 | 8,349 | Upgrade
|
| Interest Expense | -2,112 | -2,363 | -2,428 | -2,711 | -3,135 | -3,693 | Upgrade
|
| Interest & Investment Income | 726.54 | 587.69 | 721.18 | 731.55 | 680.18 | 644.23 | Upgrade
|
| Earnings From Equity Investments | 403.86 | 417.11 | 332.34 | 313.6 | 206.85 | 140.42 | Upgrade
|
| Other Non Operating Income (Expenses) | 956.35 | 1,057 | 181.76 | 353.5 | 559.3 | 845.92 | Upgrade
|
| EBT Excluding Unusual Items | 11,533 | 10,741 | 8,549 | 8,531 | 7,647 | 6,287 | Upgrade
|
| Merger & Restructuring Charges | -9.98 | -9.98 | - | -8.61 | -1.34 | -3.6 | Upgrade
|
| Impairment of Goodwill | -82.81 | -82.81 | -85.14 | -123.75 | -588.14 | -722.59 | Upgrade
|
| Gain (Loss) on Sale of Investments | -245.48 | -220.69 | -166.16 | 124.79 | 107.87 | 47.68 | Upgrade
|
| Gain (Loss) on Sale of Assets | 59.68 | 63.85 | 334.84 | 9.61 | -17.85 | 1,083 | Upgrade
|
| Asset Writedown | -611.12 | -611.12 | -271.11 | -141.68 | -90.29 | -51.75 | Upgrade
|
| Other Unusual Items | - | - | - | 17.46 | 18.09 | - | Upgrade
|
| Pretax Income | 10,643 | 9,880 | 8,361 | 8,408 | 7,076 | 6,640 | Upgrade
|
| Income Tax Expense | 2,357 | 2,105 | 1,703 | 1,761 | 1,752 | 1,542 | Upgrade
|
| Earnings From Continuing Operations | 8,286 | 7,775 | 6,658 | 6,647 | 5,324 | 5,098 | Upgrade
|
| Minority Interest in Earnings | -4,509 | -3,921 | -3,158 | -2,879 | -2,027 | -1,811 | Upgrade
|
| Net Income | 3,777 | 3,854 | 3,500 | 3,769 | 3,297 | 3,286 | Upgrade
|
| Net Income to Common | 3,777 | 3,854 | 3,500 | 3,769 | 3,297 | 3,286 | Upgrade
|
| Net Income Growth | 11.68% | 10.11% | -7.13% | 14.31% | 0.33% | -17.38% | Upgrade
|
| Shares Outstanding (Basic) | 6,283 | 6,283 | 6,283 | 6,283 | 6,283 | 6,285 | Upgrade
|
| Shares Outstanding (Diluted) | 6,283 | 6,283 | 6,283 | 6,283 | 6,283 | 6,285 | Upgrade
|
| Shares Change (YoY) | - | - | - | -0.01% | -0.02% | - | Upgrade
|
| EPS (Basic) | 0.60 | 0.61 | 0.56 | 0.60 | 0.52 | 0.52 | Upgrade
|
| EPS (Diluted) | 0.59 | 0.61 | 0.56 | 0.60 | 0.52 | 0.52 | Upgrade
|
| EPS Growth | 10.24% | 10.11% | -7.13% | 14.32% | 0.35% | -17.38% | Upgrade
|
| Free Cash Flow | 15,853 | 13,027 | 8,542 | 10,428 | 6,537 | 6,492 | Upgrade
|
| Free Cash Flow Per Share | 2.52 | 2.07 | 1.36 | 1.66 | 1.04 | 1.03 | Upgrade
|
| Dividend Per Share | 0.237 | 0.154 | 0.142 | 0.150 | 0.120 | 0.110 | Upgrade
|
| Dividend Growth | 67.46% | 8.81% | -5.65% | 25.00% | 9.09% | -15.38% | Upgrade
|
| Gross Margin | 15.77% | 15.67% | 15.41% | 14.94% | 16.11% | 16.64% | Upgrade
|
| Operating Margin | 4.61% | 4.51% | 4.46% | 4.16% | 4.66% | 4.08% | Upgrade
|
| Profit Margin | 1.51% | 1.58% | 1.60% | 1.59% | 1.65% | 1.61% | Upgrade
|
| Free Cash Flow Margin | 6.33% | 5.32% | 3.91% | 4.40% | 3.26% | 3.18% | Upgrade
|
| EBITDA | 14,192 | 13,580 | 11,688 | 11,946 | 11,079 | 10,029 | Upgrade
|
| EBITDA Margin | 5.67% | 5.55% | 5.36% | 5.04% | 5.53% | 4.91% | Upgrade
|
| D&A For EBITDA | 2,635 | 2,539 | 1,947 | 2,103 | 1,744 | 1,680 | Upgrade
|
| EBIT | 11,558 | 11,041 | 9,741 | 9,843 | 9,335 | 8,349 | Upgrade
|
| EBIT Margin | 4.61% | 4.51% | 4.46% | 4.16% | 4.66% | 4.08% | Upgrade
|
| Effective Tax Rate | 22.14% | 21.31% | 20.37% | 20.94% | 24.76% | 23.22% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.